Long non-coding RNAs (lncRNAs) are a group of transcripts over 200 nucleotides in length that do not code for proteins. The association of the dysregulation of numerous lncRNAs with several malignancies, including lung cancer, has been frequently reported. This study aims to inspect the association of genomic and transcriptomic alterations to the lncRNA LINC00987 with lung adenocarcinoma, a subtype of lung cancer, using a bioinformatic approach. To this end, we used three publically available online databases, cBioPortal, the International Cancer Genome Consortium Data Portal and the GEPIA web server. In short, our results demonstrated that LINC00987 expression might have a tumor suppressive role in lung adenocarcinoma and levels of expression could be of prognostic value for this cancer type.
Introduction
Lung cancer is the leading cause of cancer-related death in the world among both men and women 1 . Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer and accounts for over a million cancer-related deaths each year 2, 3 . Thus, the identification of molecules involved in the initiation and development of LUAD should be a high priority and could help the early diagnosis, prognosis, and treatment of this lethal cancer.
Long non-coding RNAs (lncRNAs) are a subclass of non-protein-coding transcripts over 200 nucleotides in length that are involved in several cancer-related biological processes, including cell growth, cell proliferation, and apoptosis 4, 5 . It has been frequently reported that lncRNAs, due to their pivotal regulatory roles in the cellular events, especially cell cycle processes, can be used as cancer biomarkers 6 . HOTAIR, for example, is an oncogenic lncRNA that is being used as a biomarker for several cancers 7 . LINC00987 is a poorly known lncRNA that has been observed to be dysregulated in LUAD by microarray studies 8 . However, the genomic and transcriptomic alterations to LINC00987 lncRNA in LUAD have not yet been precisely examined.
In this study, we investigated the association of LINC00987 genomic and transcriptomic alterations with LUAD. Moreover, the relationship between the LINC00987 expression level and the overall survival (OS) of LUAD patients was inspected. To accomplish these goals, three well-known online databases, cBioPortal, the International Cancer Genome Consortium (ICGC) Data Portal and the GEPIA web server, were employed.
Methods

Genomic analysis
Copy number alterations in LINC00987 lncRNA across The Cancer Genome Atlas (TCGA) LUAD study (586 samples) were retrieved from the cBioPortal database 9, 10 . To this end, the "Putative copy-number alterations from GISTIC" and "All Tumors (586)" were selected as the genomic profile and the patient/case set, respectively. The Gene-level Analysis tool of the TCGA Copy Number Portal (Analysis Version: 2015-06-01 stddata__ 2015_04_02 regular peel-off) 11 was used to determine whether LINC00987 is located within or near any peak region of somatic copy-number alterations in LUAD (516 samples). TCGA Copy Number Portal facilitates the understanding of high resolution copy number data amassed from cancer samples in the TCGA. Furthermore, the mutations to LINC00987 lncRNA in LUAD was analyzed by means of the ICGC Data Portal (https://dcc.icgc. org) To this purpose, the "LINC00987" term was searched in the ICGC Data Portal and the projects related to the LUAD were selected from the results.
Transcriptomic analysis
The GEPIA web server 12 was used to investigate the differential expression of LINC00987 lncRNA between LUAD tumor (#483) and normal (#347) samples. To this end, the Differential Expression Analysis and the Expression DIY Boxplot tools were employed with default options. The association of the differential expression of the LINC00987 lncRNA with the OS of LUAD patients was examined using the Survival Plots tool of the GEPIA web server with default parameters.
Results
LINC00987 has genomic alterations in LUAD
Copy number alteration analysis of LINC00987 demonstrated that this lncRNA was deeply deleted in over 4 percent of LUAD sequenced cases/patients ( Figure 1a ). However, LINC00987 lncRNA was amplified in 5 out of 230 LUAD sequenced samples. Analysis of somatic copy-number alterations to LINC00987 demonstrated that this lncRNA is located within a focal peak region of deletion (chr12:2782810-17821101) in LUAD (overall frequency of deletion: 0.2578; q-value: 0.0802). In addition, our results indicated that LINC00987 was mutated in 6.06% of LUAD donors, including chr12:g.9392556T>C, chr12: g.9392654T>C, and chr12:g.9393053C>G, according to the LUNG CANCER -KR project.
LINC00987 is downregulated in LUAD
Transcriptomic analysis of LINC00987 using the GEPIA web server showed that this lncRNA was significantly downregulated (log 2 (fold change) = −1.225; adjusted p-value = 1.17e 
Discussion
The aim of this study was to examine the association of genotranscriptomic alterations of LINC00987 lncRNA with LUAD using a bioinformatic approach. There is an increasing number of publications revealing the key roles of lncRNAs in cancer development and their potential as cancer biomarker.
According to our results, LINC00987 lncRNA is deleted in a significant proportion of the LUAD cases. LINC00987 was mutated in over 6 percent of LUAD patients. Frequent deletion and functional mutations are characteristic of dysregulated tumor suppressor genes in cancer [13] [14] [15] . LINC00987 lncRNA is underexpressed in LUAD samples compared with normal samples. Furthermore, survival analysis indicated that downregulation of LINC00987 lncRNA is associated with a lower OS period in LUAD patients. These cues, (that is, the under-expression of LINC00987 in cancer and the positive association of its expression level with OS of cancer patients) are characteristic of tumor suppressor genes in cancer.
Overall, LINC00987 may be a tumor suppressive lncRNA in LUAD and could be considered as a biomarker for the diagnosis and/or prognosis of patients with this cancer type. However, further bioinformatic and experimental studies are required to decipher the precise function of LINC00987 in lung tissue and evaluate its application as a biomarker for LUAD.
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All of the results presented in this study can be directly achieved using the procedures described in the Methods section.
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